valine has been researched along with nevirapine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gozlan, M | 1 |
| Anderson, PC; Bourgon, L; Clouette, C; Cohen, E; Croteau, G; Lamarre, D; Pargellis, C; Thibeault, D; Vaillancourt, M; Wardrop, E; Yoakim, C | 1 |
| Franklin, AM; Jorgensen, WL; Rader, LH; Smith, KD; Smith, MB; Smith, RH; Taylor, EV; Tirado-Rives, J | 1 |
| Drake, AL; Emery, S; Farquhar, C; Hitti, J; John-Stewart, G; Kiarie, J; Ongecha-Owuor, F; Overbaugh, J; Richardson, BA; Roxby, AC; Wald, A | 1 |
| Drake, AL; Emery, S; Farquhar, C; John-Stewart, GC; Kiarie, JN; Matemo, DN; Ongecha-Owuor, F; Overbaugh, J; Richardson, B; Roxby, AC; Wald, A | 1 |
2 trial(s) available for valine and nevirapine
| Article | Year |
|---|---|
Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.
Topics: Acyclovir; Adolescent; Adult; Anti-HIV Agents; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Kenya; Milk, Human; Nevirapine; Placebos; Plasma; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Valacyclovir; Valine; Viral Load; Young Adult; Zidovudine | 2012 |
Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
Topics: Acyclovir; Antiviral Agents; Biomarkers; CD4 Antigens; Disease Progression; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Kenya; Linear Models; Nevirapine; Postpartum Period; Pregnancy; RNA, Viral; Valacyclovir; Valine; Zidovudine | 2012 |
3 other study(ies) available for valine and nevirapine
| Article | Year |
|---|---|
Update on HIV transmission and pathogenesis.
Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Disease Models, Animal; Genes, env; HIV; HIV Infections; HIV Protease Inhibitors; HIV-1; HLA-A Antigens; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Macaca; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Simian Immunodeficiency Virus; Thiazoles; Time Factors; Valine; Virulence; Virus Latency; Virus Replication | 1995 |
Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
Topics: Anti-HIV Agents; Drug Combinations; Drug Evaluation, Preclinical; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Nevirapine; Pyridines; Quinolines; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Valine; Virus Replication | 1997 |
Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenz.
Topics: Alkynes; Amino Acid Substitution; Anti-HIV Agents; Benzoxazines; Computer Simulation; Cyclopropanes; Drug Resistance; Drug Resistance, Viral; HIV Reverse Transcriptase; Humans; Leucine; Models, Molecular; Molecular Structure; Mutation, Missense; Nevirapine; Reverse Transcriptase Inhibitors; Thermodynamics; Tyrosine; Valine | 2008 |